The key to understanding the seemingly disconnected market movements across biotechnology, energy infrastructure, and industrial services in 2026 is understanding the underlying business models. For the past decade, Aggregation Theory primarily explained how digital companies leveraged zero marginal costs to monopolize demand. Today, however, we are witnessing the application of these principles to the physical world—what we might call the aggregation of atoms. Across diverse sectors, legacy manufacturers and nascent startups alike are desperately trying to commoditize their hardware layers while moving up the value chain to capture margins through data, ecosystem compatibility, and intellectual property licensing.

The Platformization of Biology: Twist Bioscience (TWST.US), Recursion (RXRX.US), and Bio-Rad (BIYA.US)

In the synthetic biology and AI-driven drug discovery space, the distinction between a platform and an aggregator is vividly on display. Twist Bioscience (TWST.US) recently saw its stock surge to a 52-week high after reporting fiscal Q3 revenue of USD 118.4M, a solid 23% year-over-year growth. The company’s success lies in the fact that it is fundamentally a platform—it empowers third parties by supplying synthetic DNA without taking on the binary risks of clinical trials itself. A platform empowers third parties; an aggregator, on the other hand, intermediates them. Recursion Pharmaceuticals (RXRX.US) is attempting the latter by leveraging AI to overhaul the entire drug discovery pipeline. However, navigating the physical complexities of biology is significantly harder than aggregating digital bits, as evidenced by its Q2 revenue miss of just USD 7.67M, which sent shares lower recently. Meanwhile, Bio-Rad Laboratories (BIYA.US) continues to demonstrate the resilience of established life science platforms, posting Q2 sales of USD 651M, with growth in its clinical diagnostics segment supporting its recent share price appreciation.

Energy Infrastructure and the Pivot to Licensing: QuantumScape (QS.US), Enphase Energy (ENPH.US), Canadian Solar (CSIQ.US), and Rolls-Royce (RR.US)

The most fascinating developments in the energy transition revolve around hardware companies pivoting toward software economics. Solid-state battery developer QuantumScape (QS.US) recently made a distinctly software-like strategic shift: moving away from capital-intensive manufacturing toward a licensing model for automakers, effectively pushing commercialization out to 2029. The market cheered the move, with shares jumping double digits. This is a classic example of commoditizing your complement. Similarly, Enphase Energy (ENPH.US), despite facing year-over-year revenue declines in Q2, announced that its IQ Battery 10C is now compatible with third-party solar arrays. This is an aggressive move to open its previously closed ecosystem, positioning its storage software as the central hub of home energy networks. Further upstream, Canadian Solar (CSIQ.US) continues to chase economies of scale in the physical layer with its new 670W TOPCon 3.0 modules, while industrial stalwart Rolls-Royce (RR.US) defends its traditional profit pools through formidable engineering moats in power systems and propulsion.

Intermediating Services and Data: MSCI (MSCI.US), ZenaTech (ZENA.US), and DBS Group (DBSDY.US)

Once you recognize this shift toward data and services, other strategic moves across the market form a coherent pattern. MSCI (MSCI.US) acquiring First Street to enhance its climate risk analytics is a prime example of an aggregator expanding its data supply to further lock in institutional demand. Even in hardware-heavy sectors like drones, ZenaTech (ZENA.US) is scaling its Drone-as-a-Service (DaaS) model, recently acquiring Benchmark Partners—its 27th such deal—to expand its footprint. Their recent patent filings for acoustic drones further lifted investor sentiment, proving that the ultimate business model for drones is SaaS. In the financial sector, DBS Group (DBSDY.US) delivered a record Q2 net profit of SGD 3.08B and saw its wealth management AUM cross the SGD 500B mark. By expanding its wealth centers, DBS is actively intermediating the massive cross-border capital flows reshaping the Asian wealth landscape.

Many observers look at these distinct sectors and see isolated cyclical trends. This, though, is exactly backwards. This means that across the broader economy, the profit margins for selling pure physical goods are being structurally compressed, which means that sustainable moats must be built on data capture, licensing, and ecosystem control. Which is why companies as different as battery developers and synthetic biology firms are executing remarkably similar strategic playbooks in 2026.

This article does not constitute investment advice.